Clinical Trial Update: Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating acetylcysteine to prevent renal (kidney) failure after cardiac bypass surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Minneapolis Veterans Affairs Medical Center | Conditions: Kidney Failure | Phase 1, Phase 2 | Status: COMPLETED